Valuation: Provexis plc

Market Cap 22.29M 29.81M 26.62M 24.59M 41.69M 2.83B 42.38M 296M 117M 1.48B 112M 109M 4.67B P/E 2025
-22.6x
P/E 2026 -50.2x
Enterprise Value 21.39M 28.62M 25.55M 23.61M 40.02M 2.72B 40.69M 284M 112M 1.42B 107M 105M 4.49B EV / Sales 2025
7.62x
EV / Sales 2026 19.2x
Free-Float
79.16%
Yield 2025 *
-
Yield 2026 -
1 week+11.76%
Current month+2.70%
1 month+13.77%
3 months-20.50%
6 months-9.52%
Current year+5.56%
1 week 0.8
Extreme 0.8
1.05
1 month 0.72
Extreme 0.72
1.1
Current year 0.72
Extreme 0.72
1.55
1 year 0.55
Extreme 0.55
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer 61 -
Chief Tech/Sci/R&D Officer 53 31/12/1999
Director TitleAgeSince
Director/Board Member 61 10/11/2010
Chairman 80 31/05/2005
Director/Board Member 53 11/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
07/01/25 Free

Chief Executive Officer

30,000,000 1.2788%
24/01/23 Free

Chief Executive Officer

17,000,000 0.7665%
24/01/23 Free

Chief Technology Officer

17,000,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+11.76%+53.97%+57.81% 29.81M
-0.79%+1.54%+4.48%-15.07% 261B
-2.13%-0.17%+4.99%-2.87% 81.43B
+3.29%-0.04%+45.39%+549.46% 46.32B
-0.22%+1.10%-19.98%+13.43% 44.84B
+0.38%-2.99%+26.54%+12.79% 38.62B
-3.42%-0.70%-5.43%-12.77% 34.09B
-1.40%-5.07%+16.73%+80.59% 30.83B
+3.17%-0.26%-10.54%-1.48% 29.7B
-1.16%+4.73%-1.78%-22.69% 29.41B
Average -0.22%+1.09%+11.44%+65.92% 59.62B
Weighted average by Cap. -0.54%+0.48%+6.33%+39.78%

Financials

2025 2026
Net sales 1.29M 1.73M 1.54M 1.43M 2.42M 164M 2.46M 17.16M 6.79M 85.97M 6.49M 6.35M 271M 1.26M 1.69M 1.51M 1.4M 2.37M 161M 2.4M 16.79M 6.65M 84.13M 6.35M 6.21M 265M
Net income -453K -606K -541K -500K -847K -57.49M -861K -6.01M -2.38M -30.12M -2.27M -2.22M -94.96M -503K -672K -601K -555K -941K -63.84M -956K -6.68M -2.64M -33.45M -2.52M -2.47M -105M
Net Debt -708K -947K -846K -781K -1.32M -89.91M -1.35M -9.4M -3.72M -47.11M -3.55M -3.48M -149M -893K -1.19M -1.07M -986K -1.67M -113M -1.7M -11.86M -4.7M -59.42M -4.48M -4.39M -187M
Projected Income Statement - Annual - Provexis plc
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
23/10/26 GBX 0.9500 0.00% 96,539
22/10/26 GBX 0.9500 +5.56% 76,998
21/10/26 GBX 0.9000 0.00% 220,777
20/10/26 GBX 0.9000 +12.50% 83,476
19/10/26 GBX 0.8000 -5.88% 1,078,198